"RMD's world-class research continues to be on the cutting edge of new technologies," said Peter Sulick, Dynasil's Chairman of the Board, Chief Executive Officer and President. "Government agencies continue to tap our highly specialized materials research expertise to develop technology for critical medical and scientific research applications."
These awards focus on the development of advanced radiation detectors for NASA's space exploration missions, biotechnology for the National Institute of Health, and new radiation detection materials to assist the Department of Energy's scientific research programs.
"The research projects RMD is undertaking through these programs exemplify some of the world's most demanding medical and scientific research needs," said Kanai Shah, Ph.D., President of Dynasil's RMD subsidiary. "These grants capitalize on our technical and scientific capability in the development of scintillation materials and instrumentation. Dynasil is proud to partner with all of these agencies on these initiatives."
Dynasil Corporation of America (NASDAQ: DYSL) develops and manufactures optics and photonics products, optical detection and analysis technology and components for the homeland security, medical and industrial markets. Combining world-class expertise in research and materials science with extensive experience in manufacturing and product development, Dynasil is commercializing products including dual-mode radiation detection solutions for Homeland Security and commercial applications and sensors for non-destructive testing. Dynasil has an impressive and growing portfolio of issued and pending U.S. patents. The Company is based in Newton, MA, with additional operations in MA, MN, NY, NJ and the United Kingdom. More information about the Company is available at www.dynasil.com.
This news release may contain forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements regarding future events and our future results are based on current expectations, estimates, forecasts, and projections and the beliefs and assumptions of our management, including, without limitation, our expectations regarding results of operations, the commercialization of our technology and the strength of our intellectual property portfolio. These forward-looking statements may be identified by the use of words such as "plans", "intends," "may," "could," "expect," "estimate," "anticipate," "continue" or similar terms, though not all forward-looking statements contain such words. The actual results of the future events described in such forward looking statements could differ materially from those stated in such forward looking statements due to a number of important factors. These factors that could cause actual results to differ from those anticipated or predicted include, without limitation, the size and growth of the potential markets for our products and our ability to serve those markets, the rate and degree of market acceptance of any of our products, general economic conditions, costs and availability of raw materials and management information systems, our ability to obtain and maintain intellectual property protection for our products, competition, the loss of key management and technical personnel, our ability to obtain timely payment of our invoices to governmental customers, litigation, the effect of governmental regulatory developments, the availability of financing sources, our ability to identify and execute on acquisition opportunities and integrate such acquisitions into our business, and seasonality, as well as the uncertainties set forth in the Company's 2015 Annual Report on Form 10 K, as filed on December 17, 2015, including the risk factors contained in Item 1a, and from time to time in the Company's other filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Dynasil Corporation of America
Phone: (617) 668-6855
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dynasils-rmd-subsidiary-awarded-38-million-in-technology-development-grants-by-nasa-national-institute-of-health-and-department-of-energy-300266060.html
SOURCE Dynasil Corporation of America